CommercialCoverageHigh impact
Artificial Lumbar Intervertebral Disc 7.01.63
Excellus BlueCross BlueShield·Orthopedics, Neurosurgery, Pain Management·Bone & Joints (Orthopedic)
Effective date
Oct 15, 2025
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has updated their medical policy for artificial lumbar intervertebral disc procedures, effective October 15, 2025. The policy establishes detailed criteria for when lumbar total disc arthroplasty is considered medically appropriate, including specific age requirements (18-60 years), single-level disc involvement at L3-4, L4-5, or L5-S1, and mandatory 6-month conservative treatment failure.
Action Required
Before October 15, 2025: Billing and prior authorization teams must update procedures for artificial lumbar disc cases to ensure all new criteria are met before submission. Create checklist including age verification (18-60 years), single-level involvement confirmation at L3-4/L4-5/L5-S1 only, documentation of 6-month conservative treatment failure, and absence of contraindications like osteoporosis or spinal stenosis. Train staff on new documentation requirements including advanced imaging reports and functional limitation assessments. Claims not meeting these specific criteria will be denied.